Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 in Patients Who Require Parenteral Nutrition

Phase 3 Recruiting 60 enrolled Yuhan Corporation

RandomizedParallel-groupOpen-labelTreatment

Summary

A Randomized, Open-labeled, Multi-center, Active-controlled, Parallel-group Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 versus NTCB-C in patients who require parenteral nutrition

Timeline

Start: 2024-12-04
Primary completion: 2025-07-18
Completion: 2025-07-18

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	NTCB-C	Unknown	—	—
Subject	NTCB02-1	Unknown	—	—

Indications

No indication recorded.